Briefing 006/24: Category A drug reimbursement reforms FAQs
Published on: 8th March 2024 | Updated on: 3rd July 2024
From April 2024, a transition to new arrangements for the setting of Drug Tariff Category A reimbursement prices will be implemented by the Department of Health and Social Care (DHSC). The changes to Category A, imposed by DHSC, form part of a series of community pharmacy drug reimbursement reforms following a public consultation in 2019.
This briefing covers Frequently Asked Question about the changes and transition period.
Briefing 006/24: Category A drug reimbursement reforms FAQs
For more information on this topic please email ds.team@cpe.org.uk
